Deutsche Bank analyst George Hill raised the firm’s price target on HealthEquity to $72 from $68 and keeps a Buy rating on the shares. The analyst revised estimates ahead of the consensus following the company’s recent results and investor presentations.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HQY:
- HealthEquity announces HSA sales outlook
- HealthEquity Announces Record HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference
- Sharecare named Top Pick for first half of 2023 at BTIG
- Fly Insider: Willdan Group, Medtronic among weeks’ notable insider transactions
- HealthEquity bullish Fresh Pick designation extended at Baird